Top Markets
#1 Akedo Akedo +61.77%
#2 Glidr Glidr +51.75%
#3 DOVU DOVU +50.05%
#4 Velvet Velvet +41.65%
#5 Black Phoenix Black Phoenix +34.60%
#6 τemplar τemplar +27.06%
#7 Not in Employment, Education, or Training Not in Employment, Education, or Training +18.57%
#8 Bitway Bitway +17.22%
#9 Perle Perle +16.80%
#10 Cap Cap +16.64%
Coin of the day
Akedo Akedo
Configurações
Idioma
PORTUGUêS
Moeda
USD
Tema
Altamira Therapeutics Ltd. Altamira Therapeutics Ltd.

Altamira Therapeutics Ltd.

CYTO
Classificação em ações #38206
Altamira Therapeutics Ltd. is a biotechnology firm dedicated to pioneering new... Altamira Therapeutics Ltd. is a biotechnology firm dedicated to pioneering new treatments for critical medical needs that are currently underserved. Its marketed offerings include Bentrio, a non-pharmaceutical nasal spray designed for individual protection against prevalent airborne viruses and allergens. The company is also heavily invested in developing RNA therapeutics specifically for extrahepatic targets. This includes their preclinical OligoPhore and SemaPhore platforms, engineered for the effective delivery of oligonucleotides and mRNA. In its clinical-stage portfolio, AM-125 is undergoing Phase II trials for the intranasal treatment of vertigo. Additionally, Keyzilen and Sonsuvi are both in Phase III clinical development; Keyzilen is focused on acute inner ear tinnitus, and Sonsuvi addresses acute inner ear hearing loss. Established in 2003 and headquartered in Hamilton, Bermuda, Altamira Therapeutics conducts operations across Switzerland, the United States, Europe, and Australia. The company officially adopted the name Altamira Therapeutics Ltd. in July 2021, prior to which it was known as Auris Medical Holding Ltd.
Preço da ação
$0.3
Última sincronização: 2026-02-10
Valor de mercado
$1.13M
Variação (1 dia)
0.00%
Variação (1 ano)
328.57%
País
BM
Negociar Altamira Therapeutics Ltd. (CYTO)

Categoria

Healthcare
Histórico de preços das ações de Altamira Therapeutics Ltd. (CYTO)
Preço de fecho mais alto: $0.30 em 2026-02-01

Preço de fecho mais baixo: $502.51K em 2014-08-01
Histórico de preços das ações da Altamira Therapeutics Ltd. de 2014 a 2026
Desempenho anual do preço das ações
Ano Desempenho
2026 (TTM) 0.00%
2025 -8.12%
2024 -93.34%
2023 -95.12%
2022 -83.04%
2021 -50.21%
2020 106.19%
2019 -84.04%
2018 -90.18%
2017 -62.31%
2016 -66.97%
2015 -7.95%
2014 0.00%
Preço das ações de empresas similares ou concorrentes
Empresa Preço da ação Variação 1a% País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $505.24 29.45%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $846.09 29.68%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $731.69 7.13%
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 $1.07K -6.40%
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $251.82 11.25%
BE